Corbus Pharmaceuticals Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IFP ADVISORS, INC | 04/18/2023 | 100 | $595 | -75.00% | 0.00% |
| SYNOVUS FINANCIAL CORP | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| JPMORGAN CHASE & CO | 05/18/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 07/14/2023 | 0 | $0 | -100.00% | 0.00% |
| FMR LLC | 08/11/2023 | 0 | $0 | -100.00% | 0.00% |
| PINNACLE ASSOCIATES LTD | 05/05/2023 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| COMERICA SECURITIES,INC. | 04/27/2023 | 0 | $0 | -100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| STONEX GROUP INC. | 08/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 04/11/2023 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| TEKLA CAPITAL MANAGEMENT LLC | 05/10/2023 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| HBK SORCE ADVISORY LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| BANK OF NEW YORK MELLON CORP | 05/09/2023 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 05/10/2023 | 0 | $0 | -100.00% | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 05/11/2023 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| SIGMA PLANNING CORP | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| SANDY SPRING BANK | 05/05/2023 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| B. RILEY WEALTH ADVISORS, INC. | 05/17/2023 | 0 | $0 | -100.00% | 0.00% |
| NEUBERGER BERMAN GROUP LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| HAP TRADING, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/09/2023 | 0 | $0 | -100.00% | 0.00% |
| CUTLER GROUP LLC / CA | 05/01/2023 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2023 | 0 | $0 | -100.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 05/20/2024 | 0 | $0 | -100.00% | 0.00% |
| MCADAM, LLC | 04/24/2023 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Corbus Pharmaceuticals Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Corbus Pharmaceuticals Holdings, Inc.. The most heavily invested institutionals were:
Kingsbury Capital Investment Advisors LLC: 33,700
American Portfolios Advisors: 2,312
EXANE DERIVATIVES: 2,650
PARAMETRIC PORTFOLIO ASSOCIATES LLC: 0
Investors Financial Group, LLC: 0
Berman Capital Advisors, LLC: 0
0.00% of Corbus Pharmaceuticals Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.07 M shares in the last 24 months. This purchase volume represents approximately $15.84 M in transactions.